Robeco Schweiz Ag Meridian Bioscience Inc Transaction History

Robeco Schweiz Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$15.51 - $17.61 $393,954 - $447,294	-25,400 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$14.52 - $19.72 $219,252 - $297,772	15,100 Added 146.6%	25,400 $435,000
Q3 2018 Oct 30, 2018	BUY	$14.85 - $16.35 $100,980 - $111,180	6,800 Added 194.29%	10,300 $153,000
Q2 2018 Aug 09, 2018	BUY	$13.8 - $16.8 $17,125 - $20,848	1,241 Added 54.94%	3,500 $56,000
Q1 2018 May 16, 2018	SELL	$13.8 - $16.2 $34,155 - $40,095	-2,475 Reduced 52.28%	2,259 $32,000
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $64,145 - $74,797	4,734	4,734 $67,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Robeco Schweiz Ag, based on Form 13F filings with the SEC.

Stay updated on Robeco Schweiz Ag with notifications on news.